SCHEMBL5898764

SCHEMBL5898764

O/N=C/c1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444944 1.00
SCHEMBL3079633 1.00
Hydrochloric Acid SCHEMBL29417498 0.98
SCHEMBL28842609 0.80 ALDH1A1 (0.57)
SCHEMBL1253529 0.80 ALDH1A1 (0.57)
SCHEMBL3706143 0.76
SCHEMBL10899181 0.76
SCHEMBL3706144 0.76
SCHEMBL10899176 0.76
SCHEMBL17149378 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030215929-A1 Rhodococcus gene encoding aldoxime dehydratase E. I. DU PONT DE NEMOURS AND COMPANY 2003-11-20 US claimed
US-20210107910-A1 Compositions and Methods of Using the Same for Treatment of Neurodegenerative and Mitochondrial Disease MITOKININ, INC. (US) 2021-04-15 US disclosed
US-10851109-B2 Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease MITOKININ LLC (US) 2020-12-01 US disclosed
US-20190194207-A1 COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE MITOKININ INC (US) 2019-06-27 US disclosed
US-10174033-B2 N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2019-01-08 US disclosed
US-10167286-B2 Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease MITOKININ, INC. (US) 2019-01-01 US disclosed
US-20170190704-A1 COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE Mitokinin, LLC (US) 2017-07-06 US disclosed
US-20170190704-A1 COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE Mitokinin, LLC (US) 2017-07-06 US disclosed
US-9411226-B2 Chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-08-09 US disclosed
US-9411226-B2 Chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-08-09 US disclosed
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2013-02-21 US disclosed
EP-2511283-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-10-17 EP disclosed
US-7057030-B2 Rhodococcus gene encoding aldoxime dehydratase E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-06-06 US disclosed
US-20040063780-A1 Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes CHUGAI SEIYAKU KABUSHIKI KAISHA 2004-04-01 US disclosed
US-20030215929-A1 Rhodococcus gene encoding aldoxime dehydratase E. I. DU PONT DE NEMOURS AND COMPANY 2003-11-20 US disclosed
EP-0099091-B1 HEXAHYDRODIOXOPYRIMIDINES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1986-10-29 EP disclosed
US-4536504-A ANTITUMOR, ANTIVIRAL, AND ANTIBACTERIAL AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-08-20 US disclosed
EP-0099091-A1 Hexahydrodioxopyrimidines, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-01-25 EP disclosed
EP-0083293-A1 Removal of acrylonitrile from latex with oximes THE GOODYEAR TIRE & RUBBER COMPANY (US) 1983-07-06 EP disclosed
US-4365027-A TO FORM CYANOETHYL OXIMINO ETHER LINKAGE THE GOODYEAR TIRE & RUBBER COMPANY (US) 1982-12-21 US disclosed